AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc.
University of Chicago
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
BeiGene
M.D. Anderson Cancer Center
Mayo Clinic
Cyteir Therapeutics, Inc.
University Hospital Southampton NHS Foundation Trust
M.D. Anderson Cancer Center
Nordic Nanovector
Gilead Sciences
Case Comprehensive Cancer Center
City of Hope Medical Center
University of Nebraska
Hoffmann-La Roche
SymBio Pharmaceuticals
National Cancer Institute (NCI)
Celgene
University of Nebraska
Hoffmann-La Roche
Incyte Corporation
University Hospital Southampton NHS Foundation Trust
University of Nebraska
Genentech, Inc.
Hoffmann-La Roche
Shanghai Henlius Biotech
Alexion Pharmaceuticals, Inc.
Pharmacyclics LLC.
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
AbbVie
St. Petersburg State Pavlov Medical University
Hoffmann-La Roche
La Raza Medical Center
Weill Medical College of Cornell University
Hoffmann-La Roche
Mayo Clinic
Hoffmann-La Roche
MedImmune LLC
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Genentech, Inc.
M.D. Anderson Cancer Center
Acrotech Biopharma Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)